• International Journal of Technology (IJTech)
  • Vol 14, No 7 (2023)

The Effect of Umbilical Cord Blood Serum and Platelet-Rich Plasma Coatings on the Characteristics of Poly(-caprolactone) Scaffolds for Skin Tissue Engineering Applications

The Effect of Umbilical Cord Blood Serum and Platelet-Rich Plasma Coatings on the Characteristics of Poly(-caprolactone) Scaffolds for Skin Tissue Engineering Applications

Title: The Effect of Umbilical Cord Blood Serum and Platelet-Rich Plasma Coatings on the Characteristics of Poly(-caprolactone) Scaffolds for Skin Tissue Engineering Applications
Retno Wahyu Nurhayati, Auzan Luthfi Laksono, Assyafiya Salwa, Azizah Intan Pangesty, Yudan Whulanza, Wildan Mubarok

Corresponding email:


Cite this article as:
Nurhayati, R.W., Laksono, A.L., Salwa, A., Pangesty, A.I., Whulanza, Y., Mubarok, W., 2023. The Effect of Umbilical Cord Blood Serum and Platelet-Rich Plasma Coatings on the Characteristics of Poly (-caprolactone) Scaffolds for Skin Tissue Engineering Applications. International Journal of Technology. Volume 14(7), pp. 1596-1604

262
Downloads
Retno Wahyu Nurhayati - Universitas Indonesia
-
Auzan Luthfi Laksono Universitas Indonesia
Assyafiya Salwa Universitas Indonesia
Azizah Intan Pangesty Universitas Indonesia
Yudan Whulanza Universitas Indonesia
Wildan Mubarok Osaka University
Email to Corresponding Author

Abstract
The Effect of Umbilical Cord Blood Serum and Platelet-Rich Plasma Coatings on the Characteristics of Poly(-caprolactone) Scaffolds for Skin Tissue Engineering Applications

The need for effective artificial skin as a substitute for damaged skin in chronic wound therapy is recently growing. Poly(caprolactone) (PCL) has been identified as a potential material for artificial skin scaffolds due to its exceptional mechanical properties and biocompatibility. However, PCL lacks sufficient bioactivity, necessitating the introduction of bioactive molecules to scaffolds. Human umbilical cord blood serum (UCBS) and platelet-rich plasma (PRP), rich in bioactive molecules, are promising coating materials for PCL-based scaffolds. Therefore, this research aimed to investigate the effect of UCBS and PRP coatings on the mechanical properties, cytotoxicity, and cell attachment ability of PCL scaffolds. Scaffolds prepared through glutaraldehyde-mediated cross-linking of 20% (w/v) PCL followed by freeze-drying were immersed with UCBS or PRP overnight. Coating scaffolds with UCBS generated a significantly lower Young’s modulus (0.20 MPa) compared to non-coated counterparts (0.27 MPa), while PRP-coated scaffolds showed no substantial change (0.24 MPa). Both UCBS and PRP coatings significantly increased (p < 0.05) the viability and attachment of primary human fibroblast cells on scaffolds, showing the potential to enhance PCL cytocompatibility for artificial skin.

Artificial skin; Fibroblasts; Human umbilical cord blood serum; Platelet-rich plasma; Poly(-caprolactone)

Introduction

Natural A chronic wound is a significant healthcare challenge, affecting a large population globally, with an estimated occurrence ranging from 1.51 to 2.21 cases per 1,000 individuals (Martinengo et al., 2019). This is commonly managed with skin graft therapy, but the process presents various limitations, such as donor shortages, risk of disease transmission, immunogenicity, and high medical costs (Chandika et al., 2021). In response, the development of artificial skin has become a promising alternative treatment.

Artificial skin, comprising cells, scaffolds, and bioactive molecules, holds great potential for tissue regeneration and wound healing (Chung et al., 2020). While cells and bioactive molecules are widely available, current research focuses on identifying biologically and physicochemically compatible scaffolds to create effective artificial skin constructs.

Poly(caprolactone) (PCL), a hydrophobic semi-crystalline polyester synthesized by ring-opening polymerization of caprolactone (Homaeigohar dan Boccaccini, 2022), possesses desirable properties for scaffolds applications in tissue engineering (Vach-Agocsova et al., 2023; Gao et al., 2018; Siddiqui et al., 2018), including artificial skin. Despite its biocompatibility, mechanical strength, low melting point (60°C), and versatility in producing various shapes and porous structures, PCL has relatively low inherent bioactivity (Petretta et al., 2021). This limitation necessitates the incorporation of additional bioactive molecules on the scaffold's surface.

Surface properties, including surface topography, hydrophilicity, and chemical composition, often influence cell-substrate interactions (Dewi et al., 2020). Previous research explored the application of collagen in coatings for promoting cell adhesion (Sharif et al., 2017) and the modification of growth factors such as vascular endothelial growth factors (VEGF) and bone morphogenic protein-2 (BMP-2) on PCL-based scaffolds (Qin et al., 2022; Suárez-González et al., 2012). However, the limited availability, high cost, and immune-stimulating potential of these factors, specifically those from non-human sources, pose significant challenges (Mariani et al., 2019). Umbilical cord blood serum (UCBS) and platelet-rich plasma (PRP) are promising alternative sources rich in bioactive molecules that can enhance PCL scaffold bioactivity. UCBS contains cytokines and extracellular matrix proteins (Maharajan et al., 2021), along with growth factors produced by Umbilical Cord Mesenchymal Stem Cells (Nurhayati et al., 2021a). Meanwhile, PRP comprises platelets, growth factors, and fibrinogen crucial for cell attachment and migration (Maharajan et al., 2021; Nurhayati et al., 2021a; Devereaux et al., 2020; Pavlovic et al., 2016).

Coating PCL scaffolds with UCBS/PRP allows bioactive molecules to interact with seeded cells, promoting attachment, proliferation, and functional behavior (Francavilla and O’Brien, 2022; Wheeler and Yarden, 2015). Moreover, the immunomodulatory properties of UCBS and PRP can modulate the immune response and mitigate inflammation, reducing rejection of the artificial skin constructs (Sriram et al., 2023; Lotfinejad et al., 2021). Using UCBS/PRP as coating materials presents a cost-effective and easily accessible solution compared to commercial growth factor supplements.  properties.

Despite the advantages of UCBS and PRP, their applications as coating materials have not been explored. Therefore, this research aimed to investigate the effect of UCBS and PRP coatings on the characteristics of PCL scaffolds for skin tissue engineering, as well as evaluate the impact exerted on the viability and adhesion of primary human fibroblast cells (Figure 1).

Figure 1 Conceptual scheme of this research (created with BioRender.com) 

Experimental Methods

2.1. Ethical Clearance

      Ethical clearance with Approval No. KET-1003/UN2.F1/ETIK/PPM.00.02/2021 was obtained from the Ethical Committee for Medical Research of the Faculty of Medicine Universitas Indonesia-Dr. Cipto Mangunkusumo General Hospital.

2.2. Materials

The materials used in this research included PCL (Mn=80,000), acetic acid, glutaraldehyde, and calcium chloride (CaCl2), purchased from Sigma-Aldrich (St. Louis, MO, USA). Additionally, outdated human PRP was obtained from the Indonesian Red Cross (Jakarta, Indonesia). Dimethylsulfoxide (DMSO) was procured from Molecular Probes (Eugene, OR, USA). Dulbecco's Modified Eagle Medium low glucose (DMEM; glucose concentration 1 g/L), fetal bovine serum (FBS), penicillin/streptomycin, phosphate-buffered saline (PBS; pH 7.4), and trypan blue were acquired from Gibco (New York, NY, USA). The 2,5-diphenyl-2H-tetrazolium bromide (MTT) solution was purchased from Invitrogen (Carlsbad, CA, USA). 

2.3. Scaffolds Fabrication and Coating

        A 20% (w/v) PCL solution was prepared by dissolving PCL in glacial acetic acid at 60°C for 1 h. This was then transferred into a 24-well plate, frozen at -20°C overnight, and treated with 5% (v/v) glutaraldehyde for 30 min. The resulting frozen scaffolds were freeze-dried for 5 h at 0.5 atm and -120°C. For coating, UCBS and PRP solution were mixed with 0.5 mM CaCl2 at a ratio of 9:1. The freeze-dried PCL scaffolds were washed with PBS and immersed in UCBS and PRP solution at 37°C overnight, then stored at  for subsequent analysis.

2.4.  Mechanical Property Measurement

       The mechanical properties of scaffolds were evaluated using an Instron Universal Testing Machine (UTM, 6800, Instron, Norwood, MA, USA). Scaffolds with a 1 cm diameter were horizontally placed between UTM pressure plates and subjected to a compressive force at a controlled rate of 50 mm/min, reaching a maximum force of 500 N until complete crushing occurred. Young’s modulus was determined based on the stress-strain curve in the range of 0% -1.2% strain (Figure 2a).

2.5.  Isolation and Culture of Human Primary Fibroblast Cells

        Human primary fibroblast cells were isolated from discarded skin following C-section surgery using an explant method (Nurhayati et al., 2019). The skin tissue was sterilized with 0.5% (v/v) povidone-iodine in PBS, cut into small pieces (~5 mm), and placed in a 24-well plate. Approximately 200 µL of culture medium containing DMEM, 1% (v/v) penicillin/streptomycin, and 10% (v/v) FBS was added to the well to prevent tissue floatation and ensure complete coverage. Fibroblast cells originating from the explanted tissue were collected through trypsinization and subsequently cultured in a humidified incubator at 37 with 5% CO2.

2.6.  Isolation of Umbilical Cord Blood Serum

        Human UCBS was isolated from umbilical cord blood obtained post-C-section surgery using a gradient density centrifugation method (Nurhayati et al., 2021b). The blood was pipetted onto the Ficoll solution, centrifuged at 400 × g for 10 min, and the top layer containing UCBS was carefully transferred to a new tube and filtered with a 0.2 µm membrane filter.

2.7.  Cell Viability Assay

        Cell viability was assessed using an MTT assay, where the prepared scaffolds were initially immersed in a 1.5 mL culture medium. At 24, 48, and 72 h, 500 µL medium was collected and stored at 4. Fibroblast cells were seeded in a 96-well plate at a density of 7.0 × 103 cells/well. After reaching 80% confluence, the culture medium was replaced with a 100  size for immersion at the respective time points. After 24 h, cells were incubated with the culture medium mixed with MTT solution at a ratio of 9:1. Following a 4 h period, DMSO was added to stop the reaction, and the absorbance at 570 nm was measured using a microplate reader (Varioskan Lux, Thermofisher Scientific, Waltham, MA, USA), then cell viability was calculated with Formula (1):


        Where ODs shows absorbance of the sample (cells exposed to medium incubated with scaffolds), ODc signifies absorbance of cultured cells, and ODm represents absorbance of culture medium as blank.

2.8.  Cell Attachment Test

        Scaffolds were individually placed on an ultra-low attachment 6-well plate supplied with 3 mL culture medium to ensure complete submersion and fibroblast cells were seeded at a density of 1.0 × 105 cells/well. After 2, 4, and 6 h of culture, non-attached cells were counted using a hemocytometer based on a dye exclusion method, and cell attachment was calculated using Formula (2):


        Where n0 indicates the initial cell number during seeding and nf denotes the number of non-attached cells in the culture medium.

2.9.  Statistical Analysis

        All experiments were performed three times (n = 3), and data were expressed as mean ± standard deviation (S.D.). Statistical analyses were conducted with GraphPad Prism 9 (GraphPad Software Inc., Boston, MA, USA), using one-way ANOVA for Young’s modulus data and two-way ANOVA for cell viability and attachment data. A post-hoc t-test was carried out using Tukey HSD, considering results with p < 0.05 as statistically significant.

Results and Discussion

3.1.  Mechanical Properties

The influence of UCBS and PRP coatings was examined on the PCL scaffold's mechanical properties. The mechanical properties of the scaffold are a critical factor in tissue engineering as they govern the cell's behavior (Mubarok, Elvitigala, and Sakai 2022; Mubarok, Qu, and Sakai, 2021; Nadhif et al., 2020). Herein, the mechanical properties were evaluated by measuring Young’s modulus based on the stress-strain curve (Figure 2a), and the result was depicted in Figure 2b. Coating PCL scaffolds with PRP caused no substantial changes (p > 0.05, Tukey HSD), while UCBS-coated PCL showed a significantly lower Young’s modulus (p < 0.05, Tukey HSD) compared to the non-coated counterparts.


Figure 2 Influence of UCBS and PRP coatings on the mechanical properties of PCL scaffolds. (a) Stress-strain curve and (b) Young’s modulus of scaffolds. Error bars represent S.D. (n = 3). * p < 0.05, ns: no significant difference (p > 0.05), determined by Tukey HSD analysis

        The differences among scaffolds could be attributed to the inherent components of UCBS and PRP (Table 1). UCBS, known for high esterase content (Welzing et al., 2011), potentially degraded the ester linkage in PCL affecting the mechanical properties of scaffolds. Additionally, it might infiltrate PCL, altering the polymer network and weakening scaffolds. A similar effect was reported in recent research concerning PCL surface modification through hydrolysis with NaOH and aminolysis using hexamethylenediamine/isopropanol, leading to decreased mechanical properties due to interconnected network disruption (Yaseri et al., 2023). Meanwhile, PRP might contain smaller or no esterase, resulting in minimal interference with the PCL network. Despite these alterations, all PCL-based scaffolds maintained Young’s modulus values between 0.20-0.27 MPa, close to the range observed in human skin (0.135 MPa - 0.169 MPa) (Nokoorani et al., 2021), ensuring a suitable physical environment for skin cells.

Table 1 Summary of UCBS and PRP components and the functions


3.2.  Cell Viability Assay

The viability of human primary fibroblast cells exposed to the culture medium pre-incubated with scaffolds for 24 to 72 h was evaluated using an MTT assay capable of assessing metabolic activity. The results showed that coating PCL scaffolds with UCBS and PRP significantly improved cell viability (p < 0.05, two-way ANOVA) (Figure 3).


Figure 3 Viability of human primary fibroblast cells exposed to culture medium incubated with PCL, PCL+UCBS, and PCL+PRP scaffolds. Data are represented as mean ± S.D. (n = 3). *p < 0.05, ***p < 0.001, ns: no significant difference (p > 0.05), determined by Tukey HSD analysis

      The augmented cell viability observed in UCBS- and PRP-coated scaffolds was due to the presence of growth factors and cytokines stimulating the survival pathways (Chen et al., 2022). These coatings might prevent PCL release or degradation, preserving cell viability. Antioxidants found in both UCBS and PRP, such as superoxide dismutase, catalase, and glutathione (Shetty et al., 2007), neutralize reactive oxidative stress (ROS) and free radicals, thereby protecting cells from oxidative damage and enhancing viability (Sharif et al., 2017).

3.3.  Cell Attachment Test

The attachment of human primary fibroblast cells on scaffolds was evaluated at 2, 4, and 6 h post-seeding. According to Figure 4, the lowest percentage of cell attachment was observed at all time points. UCBS and PRP coatings containing growth factors, such as VEGF, EGF, PDGF, FGF, TGF, and IGF, significantly increased cell attachment (p < 0.05, two-way ANOVA) by stimulating adhesion (Maharajan et al., 2021; Pavlovic et al., 2016; Montero, Santos, and Fernández, 2015). The interaction between these growth factors and the fibroblast cell receptor played a crucial role in enhancing attachment. Both UCBS and PRP contained extracellular matrix components, supporting increased cell attachment. UCBS, with fibronectin serving as a ligand for  integrin expressed by fibroblasts, facilitated attachment to the extracellular matrix (Morshed et al., 2019). On the other hand, PRP comprised fibrinogen, which was converted into a fibrin matrix during the fibrin polymerization process aided by CaCl2 to function as a ligand for cell adhesion receptors (Devereaux et al., 2020). The interaction between fibrin with  integrins on fibroblast cells further promoted attachment. Additionally, the cytokine IL-6 found in UCBS upregulated integrin expression on the cell surface, increasing the adhesion and stability of attachment to scaffolds (Romanov et al., 2019).


Figure 4 The attachment of human primary fibroblast cells on PCL, PCL+UCBS, and PCL+PRP scaffolds. Data are represented as mean ± S.D. (n = 3). *p < 0.05, ns: no significant difference (p > 0.05), determined by Tukey HSD analysis

Conclusion

    In conclusion, the incorporation of UCBS and PRP as coating materials distinctly impacted the mechanical and biological properties of PCL scaffolds. UCBS moderately reduced (~25%) the stiffness of PCL scaffolds meanwhile PRP caused no significant alteration in stiffness. Both UCBS and PRP coatings significantly improved (p < 0.05) the viability and attachment of human primary fibroblast cells. These coatings could be considered a promising method for the development of artificial skin in tissue engineering applications. 

Acknowledgement

    This research was funded partially by the Q2 Scheme Research Grant (Hibah Publikasi Artikel di Jurnal Internasional Kuartil Q2 (PUTI Q2)) (NKB-832/UN2.RST/HKP.05.00/2023) provided by the Directorate of Research and Development at Universitas Indonesia and the Bilateral Exchange Program DIKTI-JSPS Joint Research Projects 2023 (No. 058/E4.4/KO/2023) from the Indonesian Ministry of Education, Culture, Research, and Technology (Kemendikbud RI) and Japan Society for the Promotion of Science (JSPS). The author (WM) was funded by the JSPS Postdoctoral Fellowship in Japan. 

References

Chandika, P., Oh, G.-W., Heo, S.-Y., Kim, S.-C., Kim, T.-H., Kim, M.-S.,  Jung, W.-K., 2021. Electrospun Porous Bilayer Nano-fibrous Fish Collagen/ Poly(-caprolactone) (PCL) Bio-composite Scaffolds with Covalently Cross-linked Chitooligosaccharides for Full-thickness Wound-healing Applications. Materials Science and Engineering: C, Volume 121, p. 111871

Chen, K., Rao, Z., Dong, S., Chen, Y., Wang, X., Luo, Y., Gong, F., Li, X., 2022. Roles of the Fibroblast Growth Factor Signal Transduction System in Tissue Injury Repair. Burns and Trauma, Volume 10, p. tkac005

Chung, J.J., Im, H., Kim, S.H., Park, J.W., Jung, Y., 2020. Toward Biomimetic Scaffolds For Tissue Engineering: 3D Printing Techniques In Regenerative Medicine. Frontiers in Bioengineering and Biotechnology, Volume 8, p. 586406

Dewi, A.H., Yulianto, D.K., Ana, I.D., Rochmadi, R., Siswomihardjo, W., 2020. Effect of Cinnamaldehyde, an Anti-Inflammatory Agent, on the Surface Characteristics of a Plaster of Paris-CaCO 3 Hydrogel for Bone Substitution in Biomedicine. International Journal of Technology, 11(5), pp. 963–973

Devereaux, J., Dargahi, N., Fraser, S., Nurgali, K., Kiatos, D., Apostolopoulos, V., 2020. Leucocyte-rich Platelet-rich Plasma Enhances Fibroblast and Extracellular Matrix Activity: Implications in Wound Healing. International Journal of Molecular Sciences, Volume 21(18), p. 6519

Francavilla, C., O’Brien, C.S., 2022. Fibroblast Growth Factor Receptor Signalling Dysregulation and Targeting in Breast Cancer. Open Biology, Volume 12(2), p. 210373

Gao, J., Chen, S., Tang, D., Jiang, L., Shi, J., Wang, S., 2018. Mechanical Properties and Degradability of Electrospun Poly(-caprolactone) (PCL)/Plga Blended Scaffolds as Vascular Grafts. Transactions of Tianjin University, Volume 25(2), pp. 152–160

Homaeigohar, S., Boccaccini, A.R., 2022. Nature-derived and Synthetic Additives to Poly (-caprolactone) Nanofibrous systems for Biomedicine; an Updated Overview. Frontiers in Chemistry, Volume 9, p. 809676

Lotfinejad, P., Shamsasenjan, K., Baradaran, B., Safarzadeh, E., Kazemi, T., Movassaghpour, A.A., 2021. Immunomodulatory Effect of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells on Activated T-lymphocyte. Iranian Journal of Allergy, Asthma, and Immunology, Volume 20(6), PP. 711–720

Maharajan, N., Cho, G. W., Choi, J. H., Jang, C. H., 2021. Regenerative Therapy using Umbilical Cord Serum. In vivo (Athens, Greece), Volume 35(2), pp. 699–705

Mariani, E., Lisignoli, G., Borzì, R.M., Pulsatelli, L., 2019. Biomaterials: Foreign Bodies or Tuners for the Immune Response? International Journal of Molecular Sciences, Volume 20(3), p. 636

Martinengo, L., Olsson, M., Bajpai, R., Soljak, M., Upton, Z., Schmidtchen, A., Car, J., Järbrink, K., 2019. Prevalence of Chronic Wounds in the General Population: Systematic Review and Meta-analysis of Observational Studies. Annals of Epidemiology, Volume 29, pp. 8–15

Montero, E.C., Santos, M.E.F, Fernández, R.S., 2015. Platelet-rich Plasma: Applications in Dermatology. Actas Dermo-Sifiliográficas (English Edition), Volume 106(2), pp. 104–111

Morshed, A., Abbas, A.B., Hu, J., Xu, H., 2019. Shedding New Light on the Role of 3 and 5 1 Integrins in Rheumatoid Arthritis. Molecules, Volume 24(8), pp. 1537–1537

Mubarok, W., Qu, Y., Sakai, S., 2021. Influence of Hydrogen Peroxide-mediated Cross-linking and Degradation on Cell-adhesive Gelatin Hydrogels. American Chemical Society (ACS) Applied Bio Materials, Volume 4(5), pp. 4184–4190

Mubarok, W., Elvitigala, K.C.M.L., Sakai, S., 2022. Tuning Myogenesis by Controlling Gelatin Hydrogel Properties Through Hydrogen Peroxide-mediated Cross-linking and Degradation. Gels, Volume 8(6), p. 387

Nokoorani, Y.D., Shamloo, A., Bahadoran, M., Moravvej, H., 2021. Fabrication and Characterization of Scaffolds Containing Different Amounts of Allantoin for Skin Tissue Engineering. Scientific Reports, Volume 11(1), p. 16164

Nadhif, M.H., Assyarify, H., Waafi, A.K., Whulanza, Y., 2020. Reflecting on Mechanical Functionalities in Bioreactors for Tissue Engineering Purposes. International Journal of Technology, Volume 11(5), pp. 1066-1075

Nurhayati, R.W., Sandora, N., Suwarti, Nauli, R., Khoiriyah, Z., Wardhana, A., 2019. Brief Comparative Study on the Isolation and Culture Methods of Human Keratinocyte from Skin Tissue. In: Aeronautical Information Publication (AIP) Conference Proceeding Volume 2193(1)

Nurhayati, R.W., Lubis, D.S.H., Pratama, G., Agustina, E., Khoiriyah, Z., Alawiyah, K., Pawitan, J.A., 2021a. The Effects of Static and Dynamic Culture Systems on Cell Proliferation and Conditioned Media of Umbilical Cord-derived Mesenchymal Stem Cells. International Journal of Technology. Volume 12(6), pp. 1187–1197

Nurhayati, R.W., Cahyo, R.D., Pratama, G., Anggraini, D., Mubarok, W., Kobayashi, M., Antarianto, R.D., 2021b. Alginate-chitosan Microencapsulated Cells for Improving cd34+ Progenitor Maintenance and Expansion. Applied Science, 11, 7887.

Pavlovic, V., Ciric, M., Jovanovic, V., Stojanovic, P., 2016. Platelet Rich Plasma: a Short Overview of Certain Bioactive Components. Open Medicine, Volume 11(1), pp. 242247

Petretta, M., Gambardella, A., Boi, M., Berni, M., Cavallo, C., Marchiori, G., Maltarello, M.C., Bellucci, D., Fini, M., Baldini, N., Grigolo, B., Cannillo, V., 2021. Composite Scaffolds for Bone Tissue Regeneration based on Poly(-caprolactone) (PCL) and Mg-containing Bioactive Glasses. Biology (Basel), Volume 10(5), pp. 398

Qin, X., Wu, Y., Liu, S., Yang, L., Yuan, H., Cai, S., Flesch, J., Li, Z., Tang, Y., Li, X., Zhuang, Y., 2022. Surface Modification of Polycaprolactone Scaffold with Improved Biocompatibility and Controlled Growth Factor Release for Enhanced Stem Cell Differentiation. Frontiers in Bioengineering and Biotechnology, Volume 9, p. 802311

Romanov, Y.A., Vtorushina, V.V., Dugina, T.N., Romanov, A., Petrova, N.V., 2019. Human Umbilical Cord Blood Serum/plasma: Cytokine Profile and Prospective Application in Regenerative Medicine. Bulletin of Experimental Biology and Medicine, Volume 168(1), pp. 173–177

Sharif, S., Ai, J., Azami, M., Verdi, J., Atlasi, M.A., Shirian, S., Samadikuchaksaraei, A., 2017. Collagen-coated Nano-electrospun Poly(-caprolactone) (PCL) Seeded with Human Endometrial Stem Cells for Skin Tissue Engineering Applications. Journal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 106(4), pp. 1578–1586

Shetty, P., Bharucha, K., Tanavde, V., 2007. Human Umbilical Cord Blood Serum Can Replace Fetal Bovine Serum in the Culture of Mesenchymal Stem Cells. Cell Biology International, Volume 31(3), pp. 293–298

Siddiqui, N., Asawa, S., Birru, B., Baadhe, R., Rao, S., 2018. Poly(-caprolactone) (PCL)-Based Composite Scaffold Matrices for Tissue Engineering Applications. Molecular Biotechnology, Volume 60(7), pp. 506–532

Sriram, S., Hasan, S., Alqarni, A., Alam, T., Kaleem, S.M., Aziz, S., Dawasaz, A.A., Saeed, S., 2023. Efficacy of Platelet-rich Plasma Therapy in Oral Lichen Planus: a Systematic Review. Medicina (Kaunas), Volume 59(4), pp. 746–746

Suárez-González, D., Barnhart, K., Migneco, F., Flanagan, C., Hollister, S.J., Murphy, W.L., 2012. Controllable Mineral Coatings on Poly(-caprolactone) (PCL) Scaffolds as Carriers for Growth Factor Release. Biomaterials, Volume 33(2), pp. 713–721

Vach-Agocsova, S.V., Culenova, M., Birova, I., Omanikova, L., Moncmanova, B., Danisovic, L., Ziaran, S., Bakos, D., Alexy, P., 2023. Resorbable Biomaterials Used for 3D Scaffolds in Tissue Engineering: A Review. Materials, Volume 16(12), p. 4267

Welzing, L., Ebenfeld, S., Dlugay, V., Wiesen, M.H.J., Roth, B., Mueller, C., 2011. Remifentanil Degradation in Umbilical Cord Blood of Preterm Infants. Anesthesiology, Volume 114(3), pp. 570–577

Wheeler, D.L., Yarden, Y. 2015. Receptor Tyrosine Kinases: Family and Subfamilies. In: Springer International Publishing, Switzerland

Yaseri, R., Fadaie, M., Mirzaei, E., Samadian, H., Ebrahiminezhad, A., 2023. Surface modification of polycaprolactone nanofibers through hydrolysis and aminolysis: a comparative study on structural characteristics, mechanical properties, and cellular performance. Scientific Reports, Volume 13(1), p. 9434